As of 2025-07-16, the Relative Valuation of Neurobo Pharmaceuticals Inc (NRBO) is (31.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.36 USD, the upside of Neurobo Pharmaceuticals Inc based on Relative Valuation is -1426.3%.
The range of the Relative Valuation is (4.75) - (56.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.1x - 13.1x | 7.1x |
| Forward P/E multiples | 1.1x - 13.7x | 7.4x |
| Fair Price | (4.75) - (56.56) | (31.30) |
| Upside | -301.2% - -2496.5% | -1426.3% |
| Date | P/E |